ArticleExperimental eye research2026
Abnormal meibum is associated with SREBF1 mutation and IFAP Syndrome-2.
Article in Experimental eye research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Case of SREBF1-Associated Ichthyosis Follicularis, Alopecia, and Photophobia Syndrome With Recurrent Alopecia.The Journal of dermatology · 2026Article
- Lipid Composition and Thermotropic Properties of Meibum of Animal Models and Humans with Meibomian Gland Dysfunction.International journal of molecular sciences · 2025Article
- Lipid composition determines thermotropic properties of meibum of animals and humans with Meibomian gland disorders.bioRxiv : the preprint server for biology · 2025Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
The X-linked Ichthyosis Follicularis, Alopecia, and Photophobia syndrome type-2 (IFAP-2), is a condition that has been linked to a c.1579C>T mutation in the SREBF1 gene. However, the molecular implications of the mutation in Meibomian glands (MG) remain unknown. The goals of our project were to elucidate the biochemical factors associated with IFAP-2 and develop approaches for unbiased diagnosing this condition. Meibum samples were collected from normal subjects and a patient with IFAP-2-like signs and symptoms. Genetic analysis of the abnormal subject revealed the same c.1579C>T (p.Arg527Cys) mutation in the SREBF1 gene that was previously associated with IFAP-2. The meibum samples were analyzed using liquid chromatography-mass spectrometry (LC-MS), and the data were compared using multivariate statistical approaches. The LC-MS provided detailed information on the differences between the Meibomian lipid profiles of normal subjects and the IFAP-2 patient, specifically in saturated and unsaturated wax esters (SWE and UWE). Our data showed that IFAP-2 meibum was enriched with SWE which increased the SWE/UWE ratio to highly abnormal levels. The higher melting temperature of SWE compared to that of UWE correlated well with poor expressibility and abnormal thickness of IFAP-2 meibum. Thus, our study demonstrated possible links between the p.Arg527Cys mutation in SREBP1 protein, upregulation of SWE in the IFAP-2 meibum, and MG dysfunction. It also showed that LC-MS can be used as a sensitive and informative tool to reveal minute differences in the Meibomian lipidomes of the subjects with MG dysfunction, and identify molecular markers of the conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.